American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

NCT00259376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

629

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Atrial Flutter

Interventions

DRUG: Dronedarone (SR33589)
DRUG: placebo

Sponsor

Sanofi